Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Published Jun 05, 2023 18:09

Updated Jun 05, 2023 19:10

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga - Gainers

  • Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
  • Forza X1, Inc. (NASDAQ: FRZA) shares jumped 94.3% to $2.4299 after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!'
  • Chijet Motor Company, Inc. (NASDAQ: CJET) shares gained 73% to $6.63 after dipping around 33% on Friday. The stock is experiencing an upward trend in trading Monday, driven by post-IPO volatility subsequent to its debut listing on the NASDAQ on Friday.
  • CIRCOR International, Inc. (NYSE: CIR) surged 50.1% to $47.54 after the company announced an agreement to be acquired by KKR for $49 per share in cash.
  • Regencell Bioscience Holdings Limited (NASDAQ: RGC) gained 35.5% to $30.49.
  • Timber Pharmaceuticals, Inc. (NYSE: TMBR) rose 35% to $2.0139 following a positive decision from the FDA for its TMB-001 treatment.
  • Pasithea Therapeutics Corp. (NASDAQ: KTTA) climbed 30.8% to $0.5232. Lucy Scientific Discovery announced proposal to acquire Pasithea Therapeutics for $0.60 per share in cash and $0.25 per share in Lucy stock.
  • Dunxin Financial Holdings Limited (NYSE: DXF) gained 29.9% to $0.2671after gaining over 15% on Friday.
  • InnSuites Hospitality Trust (NYSE: IHT) surged 27.3% to $3.0040.
  • National CineMedia, Inc. (NASDAQ: NCMI) gained 27% to $0.38. National CineMedia announced new long-term advertising agreement with Regal Cinemas.
  • CXApp Inc. (NASDAQ: CXAI) rose 23.7% to $12.35.
  • Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) surged 20% to $1.8238.
  • Journey Medical Corporation (NASDAQ: DERM) gained 20% to $1.50.
  • CURO Group Holdings Corp. (NYSE: CURO) rose 18.8% to $1.8297.
  • BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) gained 17.7% to $2.0249 after the company signed a worldwide license agreement to develop an antibody for treatment of autoimmune and inflammatory diseases.
  • Getty Images Holdings, Inc. (NYSE: GETY) climbed 15.5% to $5.50.
  • WeWork Inc. (NYSE: WE) gained 14.7% to $0.2123.
  • Replimune Group, Inc. (NASDAQ: REPL) rose 14.6% to $21.77. Replimune presented RP1 data from the IGNYTE anti-PD1 failed melanoma cohort and RP2 Data in uveal melanoma at the ASCO.
  • TOP Financial Group Limited (NASDAQ: TOP) surged 14.3% to $8.21.
  • Amedisys, Inc. (NASDAQ: AMED) gained 14.2% to $90.79 after the company received an unsolicited proposal from Optum for $100 per share.
  • Blue Apron Holdings, Inc. (NYSE: APRN) rose 14.1% to $0.6047.
  • Scilex Holding Company (NASDAQ: SCLX) jumped 12.6% to $7.22.
  • Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) gained 11.8% to $15.22 after the company announced overall response rate of 67% and clinical benefit rate of 93% in 69 heavily pretreated RANO-HGG evaluable patients in pediatric low-grade glioma trial.
  • Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 11.8% to $0.3316. Kaspien recently announced a voluntary delisting from The Nasdaq Capital Market.
  • Bowlero Corp. (NYSE: BOWL) rose 11% to $12.88. Stifel maintained Bowlero with a Buy and raised the price target from $24 to $25.
  • Erasca, Inc. (NASDAQ: ERAS) jumped 10% to $3.18.
  • Clover Health Investments, Corp. (NASDAQ: CLOV) rose 9.3% to $0.9659.
  • Agenus Inc. (NASDAQ: AGEN) gained 9.1% to $1.7450. Agenus presented complete results for AGEN2373 at 2023 ASCO meeting.
  • ImmunoGen, Inc. (NASDAQ: IMGN) shares gained 5.9% to $15.22 after the company announced that ELAHERE demonstrated 35% reduction in the risk of disease progression or death vs chemotherapy in FRα-Positive platinum-resistant ovarian cancer.
Losers
  • Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares dipped 85% to $1.06 after the company's Phase 3 REBUILD trial did not meet its primary endpoint.
  • Castle Biosciences, Inc. (NASDAQ: CSTL) fell 48% to $11.80. Baird, SVB Securities and Lake Street lowered their price targets on the stock.
  • Cyxtera Technologies, Inc. (NASDAQ: CYXT) fell 37.2% to $0.10 after the company said, pursuant to the previously disclosed Restructuring Support Agreement it reached with certain of its lenders holding over two-thirds of its outstanding term loan, the Company and certain of its subsidiaries have initiated a pre-arranged court-supervised process under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey.
  • Mallinckrodt plc (NYSE: MNK) fell 28.6% to $1.75. Mallinckrodt is considering options including filing for bankruptcy again, according to the Wall Street Journal.
  • Yunji Inc. (NASDAQ: YJ) shares dropped 26.5% to $0.23. Yunji shares jumped over 50% on Friday after the company reported first-quarter financial results.
  • Universal Security Instruments, Inc. (NYSE: UUU) dipped 18.3% to $2.45.
  • Context Therapeutics Inc. (NASDAQ: CNTX) fell 18% to $1.0501.
  • EPAM Systems, Inc. (NASDAQ: EPAM) declined 17.7% to $213.50 after the company cut its second-quarter financial outlook.
  • Amyris, Inc. (NASDAQ: AMRS) dropped 16.2% to $0.7885. Amyris initiated strategic transformation program and secured funding to deliver the company's planned cost reduction target of approximately $250 million from cost of goods sold.
  • Comtech Telecommunications Corp. (NASDAQ: CMTL) dropped 13.7% to $10.64.
  • DMC Global Inc. (NASDAQ: BOOM) fell 13.6% to $15.65.
  • SunCar Technology Group Inc. (NASDAQ: SDA) declined 13.2% to $20.22.
  • Elevation Oncology, Inc. (NASDAQ: ELEV) dropped 12.8% to $3.0850. Wedbush maintained Elevation Oncology with an Outperform and raised the price target from $4 to $6.
  • Gannett Co., Inc. (NYSE: GCI) fell 12.7% to $1.9650.
  • Zumiez Inc. (NASDAQ: ZUMZ) declined 11.1% to $13.76. Zumiez recently posted a wider-than-expected quarterly loss.
  • IGM Biosciences, Inc. (NASDAQ: IGMS) dropped 10.9% to $12.11. Wedbush reiterated IGM Biosciences with an Outperform and maintained a $37 price target.
  • Endava plc (NYSE: DAVA) declined 10.8% to $45.97. Needham reiterated Endava with a Buy and maintained a $68 price target.
  • Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares fell 10.2% to $0.22 after gaining over 8% on Friday.
  • Cibus, Inc. (NASDAQ: CBUS) dropped 9.6% to $24.40.
  • SHL Telemedicine Ltd. (NASDAQ: SHLT) fell 9.1% to $11.55 after gaining 10% on Friday.
  • Minerva Surgical, Inc. (NASDAQ: UTRS) shares dropped 7.9% to $0.27 after surging over 46% on Friday.
  • Blueprint Medicines Corporation (NASDAQ: BPMC) fell 6.8% to $54.24. SVB Leerink downgraded Blueprint Medicines from Market Perform to Underperform and lowered the price target from $48 to $43.
  • PetMed Express, Inc. (NASDAQ: PETS) declined 5.5% to $14.79.
Get The App
Join the millions of people who stay on top of global financial markets with Investing.com.
Download Now

Now Read This: Bitcoin Falls Below This Major Level; Pepe Becomes Top Loser

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Written By: Benzinga

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes